Literature DB >> 28546266

Health-related quality of life and risk factors associated with spirometric restriction.

Stefano Guerra1,2,3,4, Anne-Elie Carsin2,3,4,5, Dirk Keidel6,7, Jordi Sunyer2,3,4,5, Bénédicte Leynaert8,9, Christer Janson10, Debbie Jarvis11, Daiana Stolz12, Thomas Rothe13, Marco Pons14, Alexander Turk15, Josep M Anto2,3,4,5, Nicole Probst-Hensch6,7.   

Abstract

The restrictive spirometric pattern is associated with a substantial morbidity and mortality burden. We sought to determine to what extent spirometric restriction is associated with impaired quality of life.We used data from two large population-based European cohorts: 6698 European Community Respiratory Health Survey (ECRHS) and 6069 Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults (SAPALDIA) adult participants. The restrictive pattern was defined as forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) ≥lower limit of normal (LLN) and FVC <LLN; an obstructive pattern was defined as FEV1/FVC <LLN independent of FVC. The Physical Component Summary and Mental Component Summary of quality of life were computed using the Short Form-36 questionnaire.In both cohorts, the restrictive pattern was associated with heavy smoking, being underweight or obese and the coexistence of respiratory symptoms. In univariate analyses, compared with the normal group, both the restrictive and obstructive pattern had significant Physical Component Summary deficits (-2.77 and -2.08, respectively, in ECRHS; -3.25 and -2.14, respectively, in SAPALDIA; all p-values <0.001). However, in models adjusted for sex, age, education, body mass index, smoking, comorbidities and respiratory symptoms, only the restrictive pattern remained significantly associated with Physical Component Summary deficits (p=0.004 in ECRHS; p=0.001 in SAPALDIA).The restrictive spirometric pattern is associated with deficits in the physical component of quality of life that are partly independent of the presence of respiratory symptoms.
Copyright ©ERS 2017.

Entities:  

Mesh:

Year:  2017        PMID: 28546266     DOI: 10.1183/13993003.02096-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  11 in total

1.  The role of growth and nutrition in the early origins of spirometric restriction in adult life: a longitudinal, multicohort, population-based study.

Authors:  Nipasiri Voraphani; Debra A Stern; Jing Zhai; Anne L Wright; Marilyn Halonen; Duane L Sherrill; Jenny Hallberg; Inger Kull; Anna Bergström; Clare S Murray; Lesley Lowe; Adnan Custovic; Wayne J Morgan; Fernando D Martinez; Erik Melén; Angela Simpson; Stefano Guerra
Journal:  Lancet Respir Med       Date:  2021-11-26       Impact factor: 30.700

2.  Significant Spirometric Transitions and Preserved Ratio Impaired Spirometry Among Ever Smokers.

Authors:  Emily S Wan; John E Hokanson; Elizabeth A Regan; Kendra A Young; Barry J Make; Dawn L DeMeo; Stefanie E Mason; Raul San Jose Estepar; James D Crapo; Edwin K Silverman
Journal:  Chest       Date:  2021-09-27       Impact factor: 9.410

3.  Vertebral fractures at hospitalization predict impaired respiratory function during follow-up of COVID-19 survivors.

Authors:  Luigi di Filippo; Nicola Compagnone; Stefano Frara; Agnese Allora; Mauro Doga; Patrizia Rovere Querini; George Cremona; Andrea Giustina
Journal:  Endocrine       Date:  2022-06-08       Impact factor: 3.925

4.  Association Between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US Adults.

Authors:  Emily S Wan; Pallavi Balte; Joseph E Schwartz; Surya P Bhatt; Patricia A Cassano; David Couper; Martha L Daviglus; Mark T Dransfield; Sina A Gharib; David R Jacobs; Ravi Kalhan; Stephanie J London; Ana Navas-Acien; George T O'Connor; Jason L Sanders; Benjamin M Smith; Wendy White; Sachin Yende; Elizabeth C Oelsner
Journal:  JAMA       Date:  2021-12-14       Impact factor: 157.335

5.  Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study.

Authors:  Emily S Wan; Spyridon Fortis; Elizabeth A Regan; John Hokanson; MeiLan K Han; Richard Casaburi; Barry J Make; James D Crapo; Dawn L DeMeo; Edwin K Silverman
Journal:  Am J Respir Crit Care Med       Date:  2018-12-01       Impact factor: 30.528

6.  Impact of the severity of restrictive spirometric pattern on nutrition, physical activity, and quality of life: results from a nationally representative database.

Authors:  Sung Jun Chung; Hwan Il Kim; Bumhee Yang; Taehee Kim; Yun Su Sim; Hyung Koo Kang; Sang-Heon Kim; Ho Joo Yoon; Hayoung Choi; Hyun Lee
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

7.  Non-invasive techniques to assess restrictive lung disease in workers exposed to free crystalline silica.

Authors:  Massimo Corradi; Giuseppina Folesani; Benedetta Robuschi; Luisella Selis; Maria Grazia Riccelli; Maria Grazia Riccelli; Roberta Andreoli; Roberta Pisi; Alfredo Chetta; Antonio Mutti
Journal:  Med Lav       Date:  2019-04-19       Impact factor: 1.275

8.  Health-Related Quality of Life and Related Factors in Persons with Preserved Ratio Impaired Spirometry: Data from the Korea National Health and Nutrition Examination Surve.

Authors:  I Re Heo; Ho Cheol Kim; Tae Hoon Kim
Journal:  Medicina (Kaunas)       Date:  2020-12-23       Impact factor: 2.430

9.  Effect of Six-Minute Walk Test and Incremental Exercise on Inspiratory Capacity, Ventilatory Constraints, Breathlessness and Exercise Performance in Sedentary Male Smokers without Airway Obstruction.

Authors:  Wassim Melliti; Rim Kammoun; Donies Masmoudi; Said Ahmaidi; Kaouthar Masmoudi; Fawaz Alassery; Habib Hamam; Mehdi Chlif
Journal:  Int J Environ Res Public Health       Date:  2021-12-01       Impact factor: 3.390

10.  Pulmonary function in patients surviving to COVID-19 pneumonia.

Authors:  Alessia Fumagalli; Clementina Misuraca; Achille Bianchi; Noemi Borsa; Simone Limonta; Sveva Maggiolini; Daniela Rita Bonardi; Andrea Corsonello; Mirko Di Rosa; Luca Soraci; Fabrizia Lattanzio; Daniele Colombo
Journal:  Infection       Date:  2020-07-28       Impact factor: 7.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.